LOGO
LOGO

Economy And The Numbers

Is A Turnaround In Sight For Semler Stock?

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Shares of Semler Scientific Inc. (SMLR), a commercial-stage medical device company, are down over 80% from their 52-week high of $53.38, recorded in February of this year, and trade around $29.

The company's flagship product is QuantaFlo, a patented, FDA-cleared point-of-care product designed to assess arterial blood flow in the extremities swiftly. QuantaFlo supports health care providers in the early diagnosis of peripheral arterial disease, even in patients who are asymptomatic.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Economic News

What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.

Global Economics Weekly Update - Aug 31 – Sep 04, 2026

September 04, 2026 15:08 ET
The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.